YLR111W Antibody

What is YLR111W and why is it studied in yeast research?

YLR111W is an uncharacterized protein in Saccharomyces cerevisiae (baker's yeast), specifically in strain 204508/S288c. This protein is of interest to researchers studying yeast genetics and proteomics because it represents one of many proteins with unknown functions in the yeast genome. Antibodies against YLR111W enable researchers to track protein expression, localization, and interactions, helping to elucidate its biological role. Understanding uncharacterized proteins like YLR111W contributes to our comprehensive knowledge of yeast cellular processes and potentially reveals novel pathways relevant to eukaryotic biology .

What are the key specifications of commercially available YLR111W antibodies?

The commercially available YLR111W antibody is a rabbit-derived polyclonal antibody specifically targeting the Saccharomyces cerevisiae strain 204508/S288c YLR111W protein. It is purified using antigen-affinity methods and belongs to the IgG isotype class. This antibody has been validated for use in enzyme-linked immunosorbent assay (ELISA) and Western Blot applications, making it suitable for protein detection and quantification experiments. Alternative names for this target include "Uncharacterized protein YLR111W" and "Putative uncharacterized protein YLR111W" with additional identifiers L2925 and L9354.4 .

How does polyclonal YLR111W antibody differ from monoclonal antibodies in research applications?

Polyclonal YLR111W antibodies, like the commercially available rabbit anti-Saccharomyces cerevisiae YLR111W, bind to multiple epitopes on the target protein, unlike monoclonal antibodies which recognize a single epitope. This multi-epitope binding creates several important research distinctions:

• Signal strength: Polyclonal antibodies typically generate stronger signals in applications like Western blots as they bind multiple sites on each target protein.

• Tolerance to protein denaturation: They maintain reactivity even if some epitopes are altered during experimental procedures.

• Batch variability: Different production lots may show variation in epitope recognition patterns.

• Specificity considerations: They may exhibit more cross-reactivity compared to monoclonal antibodies.

For YLR111W research, polyclonal antibodies are particularly valuable in initial characterization studies where protein detection sensitivity is prioritized over epitope-specific analysis .

What are the optimal protocols for using YLR111W antibody in Western blotting experiments?

For optimal Western blot results with YLR111W polyclonal antibody:

• Sample preparation:

  • Extract yeast proteins using glass bead lysis in buffer containing protease inhibitors

  • Denature samples in Laemmli buffer (containing SDS and β-mercaptoethanol) at 95°C for 5 minutes

• Gel electrophoresis and transfer:

  • Separate proteins on 10-12% SDS-PAGE gels

  • Transfer to PVDF membrane at 100V for 60 minutes in cold transfer buffer

• Blocking and antibody incubation:

  • Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

  • Dilute YLR111W antibody 1:1000 to 1:5000 in blocking solution

  • Incubate overnight at 4°C with gentle agitation

  • Wash 3-5 times with TBST, 5 minutes each

• Detection:

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:10,000-1:20,000) for 1 hour

  • Wash 3-5 times with TBST

  • Develop using enhanced chemiluminescence substrate

  • Expose to X-ray film or image using digital imager

• Controls:

  • Include wild-type and YLR111W knockout yeast samples

  • Use anti-GAPDH or anti-actin antibody as loading control

How can YLR111W antibody be effectively used in ELISA experiments?

For implementing an effective ELISA protocol with YLR111W antibody:

• Plate preparation:

  • Coat 96-well high-binding plates with anti-human kappa and lambda light chain specific mouse antibodies at 1:1 ratio diluted 1:500 in PBS or with purified YLR111W protein (1 μg/mL)

  • Incubate for 1 hour at 37°C

  • Block with 5% BSA, 0.05% Tween 20 in D-PBS

• Sample preparation:

  • Prepare yeast lysates using gentle detergent extraction methods

  • Dilute samples appropriately (initially test 1:100 dilution in triplicate)

  • Create serial dilutions to establish standard curves

• Antibody incubation:

  • Add YLR111W antibody at optimized dilution to wells

  • Incubate for 1 hour at 37°C

  • Wash thoroughly (4-5 times) with wash buffer

• Detection system:

  • Add HRP-conjugated anti-rabbit secondary antibody (1:20,000 dilution)

  • Incubate for 1 hour at 37°C

  • Develop with TMB substrate for precisely 5 minutes

  • Stop reaction with TMB stop solution

  • Read absorbance at 450 nm

• Data analysis:

  • Generate standard curves using purified YLR111W protein

  • Determine protein concentrations using linear regression

  • Apply statistical analysis for experimental comparisons

What considerations are important when designing immunofluorescence experiments using YLR111W antibody?

When designing immunofluorescence experiments with YLR111W antibody in yeast:

• Cell preparation:

  • Culture yeast cells to mid-log phase (OD600 0.6-0.8)

  • Fix with 4% paraformaldehyde for 30 minutes

  • Permeabilize cell wall with zymolyase treatment (1 mg/mL for 30 minutes)

  • Permeabilize membrane with 0.1% Triton X-100 for 5 minutes

• Blocking and antibody application:

  • Block with 3% BSA in PBS for 1 hour

  • Dilute YLR111W polyclonal antibody 1:100 to 1:500 in blocking solution

  • Incubate overnight at 4°C in humidified chamber

  • Wash extensively with PBS (at least 3-5 times)

• Detection and visualization:

  • Use fluorescently-labeled anti-rabbit secondary antibody (1:1000)

  • Counter-stain nuclei with DAPI (1 μg/mL)

  • Mount using anti-fade mounting medium

• Controls and validation:

  • Include YLR111W knockout strains as negative controls

  • Use known organelle markers (e.g., mitochondrial, nuclear, ER) for co-localization studies

  • Perform Z-stack imaging to determine precise subcellular localization

• Analysis techniques:

  • Quantify fluorescence intensity across cellular compartments

  • Measure colocalization with organelle markers using Pearson's correlation coefficient

How can researchers validate the specificity of YLR111W antibody binding?

To validate YLR111W antibody specificity:

• Genetic controls:

  • Compare immunostaining between wild-type and YLR111W deletion strains

  • Use strains with epitope-tagged YLR111W (e.g., HA, FLAG, GFP) for parallel detection

• Biochemical validation:

  • Perform peptide competition assays by pre-incubating antibody with purified YLR111W protein

  • Conduct immunoprecipitation followed by mass spectrometry to confirm target identity

  • Assess cross-reactivity with closely related yeast proteins

• Cross-platform verification:

  • Compare results across multiple techniques (Western blot, immunofluorescence, ELISA)

  • Correlate protein detection with mRNA expression data

  • Verify subcellular localization using fractionation followed by Western blotting

• Alternative antibody comparison:

  • Test multiple antibody clones targeting different epitopes of YLR111W

  • Compare results from different antibody suppliers when available

• Bioinformatic analysis:

  • Perform in silico epitope prediction to identify potential cross-reactive proteins

  • Analyze potential post-translational modifications that might affect antibody binding

What are common sources of background in YLR111W antibody experiments and how can they be minimized?

Common background sources and mitigation strategies:

Optimize washing steps (increase number, duration, and detergent concentration) and validate with appropriate negative controls for your specific experimental system .

How should researchers interpret inconsistent results between different applications using YLR111W antibody?

When encountering inconsistencies between different applications (e.g., positive Western blot but negative immunofluorescence):

• Epitope accessibility differences:

  • YLR111W epitopes may be accessible in denatured proteins (Western blot) but masked in native conformation (immunofluorescence/ELISA)

  • Solution: Try multiple fixation protocols or epitope retrieval methods

• Protein expression thresholds:

  • Different detection methods have varying sensitivity limits

  • Solution: Concentrate samples for less sensitive methods; quantify signal-to-noise ratios across techniques

• Post-translational modifications:

  • YLR111W may undergo modifications affecting antibody recognition in specific contexts

  • Solution: Use phosphatase or glycosidase treatments to assess modification impact

• Context-dependent protein interactions:

  • YLR111W may form complexes masking antibody binding sites in certain cellular environments

  • Solution: Test different extraction conditions (detergents, salt concentrations)

• Application-specific optimization:

  • Each technique requires specific antibody dilutions and conditions

  • Solution: Optimize protocols independently for each application rather than using identical conditions

• Methodological validation:

  • Verify antibody functionality in each application using known positive controls

  • Solution: Include epitope-tagged YLR111W constructs as technical validation standards

How can YLR111W antibody be incorporated into advanced proteomics workflows?

YLR111W antibody can enhance advanced proteomics research through:

• Immunoprecipitation-mass spectrometry (IP-MS):

  • Couple YLR111W antibody to protein A/G beads or directly to activated resin

  • Isolate YLR111W and associated protein complexes from yeast lysates

  • Analyze complexes through LC-MS/MS to identify interaction partners

  • Validate interactions through reciprocal IP and proximity ligation assays

• ChIP-seq applications:

  • If YLR111W has DNA-binding properties, perform chromatin immunoprecipitation

  • Sequence associated DNA fragments to identify genomic binding sites

  • Correlate binding sites with gene expression data to infer regulatory functions

• Protein dynamics studies:

  • Use YLR111W antibody in pulse-chase experiments with metabolic labeling

  • Track protein synthesis, modification, and degradation rates

  • Combine with cell fractionation to monitor subcellular trafficking

• Quantitative proteomics:

  • Implement SILAC or TMT labeling for differential expression analysis

  • Compare YLR111W levels across growth conditions or genetic backgrounds

  • Correlate with global proteomic changes to identify functional pathways

• Cross-linking mass spectrometry:

  • Apply protein cross-linking agents before immunoprecipitation

  • Identify direct binding interfaces through analysis of cross-linked peptides

  • Generate structural models of YLR111W protein complexes

What considerations are important when using machine learning approaches to improve YLR111W antibody specificity?

Implementing machine learning for YLR111W antibody optimization:

• Epitope prediction refinement:

  • Apply deep learning algorithms to predict optimal antigenic determinants

  • Train models using known epitope-paratope structures from antibody databases

  • Generate synthetic antibody sequences with potentially higher specificity

  • Computationally evaluate multiple antigen-binding simulations

• Training data requirements:

  • Establish minimum sequence diversity thresholds for model accuracy

  • Incorporate both successful and failed antibody designs to avoid bias

  • Include structural data when available to improve prediction quality

  • Validate with experimental binding affinity measurements

• Transfer learning applications:

  • Leverage pre-trained antibody design models from related systems

  • Fine-tune with YLR111W-specific binding data

  • Enable generation of high-affinity antibody sequences from limited training data

  • Compare computational predictions with experimental validation

• Developability parameter integration:

  • Incorporate developability metrics into optimization algorithms

  • Balance specificity improvement with stability and production efficiency

  • Evaluate biophysical properties of antibody candidates

  • Screen for potential cross-reactivity with host proteins

• Validation framework:

  • Design lattice-based antibody-antigen binding simulations

  • Compute synthetic antibody-antigen 3D structures

  • Establish unrestricted prospective evaluation of antibody design parameters

  • Validate computational predictions with experimental binding assays

How can researchers develop validated epitope mapping strategies for YLR111W antibody?

To develop comprehensive epitope mapping for YLR111W antibody:

• Peptide array screening:

  • Generate overlapping peptide arrays (15-mers, overlapping by 11 residues) spanning the entire YLR111W sequence

  • Probe arrays with YLR111W antibody followed by labeled secondary antibody

  • Identify reactive peptides indicating linear epitopes

  • Analyze results using specialized epitope mapping software

• Mutagenesis approaches:

  • Create alanine scanning libraries of YLR111W

  • Express mutant proteins and test antibody binding using ELISA

  • Identify critical residues required for antibody recognition

  • Construct 3D models of epitope-paratope interfaces

• Structural biology integration:

  • Implement electron microscopy-based polyclonal epitope mapping (EMPEM)

  • Visualize immunodominant serum antibody responses

  • Determine conformational epitopes through 3D reconstruction

  • Compare results with computational epitope predictions

• Cross-blocking experiments:

  • Test competition between different anti-YLR111W antibody clones

  • Identify distinct vs. overlapping epitopes using competition ELISA

  • Validate using increasing dilutions of competing antibodies

  • Map epitope clusters based on blocking patterns

• Hydrogen-deuterium exchange mass spectrometry:

  • Compare deuterium uptake of YLR111W protein alone vs. antibody-bound

  • Identify protected regions representing binding interfaces

  • Combine with computational modeling to refine epitope boundaries

  • Correlate structural data with functional antibody properties

How can YLR111W antibody be used to study protein-protein interactions in yeast?

YLR111W antibody enables multiple approaches to protein interaction studies:

• Co-immunoprecipitation (Co-IP):

  • Immobilize YLR111W antibody on protein A/G beads

  • Incubate with native yeast lysates under gentle conditions

  • Wash carefully to preserve protein complexes

  • Elute and analyze by Western blot or mass spectrometry

  • Validate interactions with reciprocal Co-IP experiments

• Proximity-dependent labeling:

  • Generate fusion constructs of YLR111W with BioID or APEX2

  • Express in yeast and induce proximity labeling

  • Capture labeled proteins using streptavidin beads

  • Compare results with direct immunoprecipitation using YLR111W antibody

  • Identify both stable and transient interaction partners

• Förster resonance energy transfer (FRET):

  • Use YLR111W antibody fragments conjugated to donor fluorophores

  • Label candidate interacting proteins with acceptor fluorophores

  • Measure energy transfer as evidence of close proximity

  • Calculate interaction distances based on FRET efficiency

• Yeast two-hybrid validation:

  • Screen for interactions using Y2H system

  • Validate positive hits through Co-IP with YLR111W antibody

  • Compare interaction profiles across different growth conditions

  • Construct interaction networks with confidence scoring

• In situ proximity ligation assay (PLA):

  • Combine YLR111W antibody with antibodies against candidate interactors

  • Apply species-specific PLA probes and ligase

  • Visualize interaction sites as fluorescent spots

  • Quantify interaction frequency in different cellular compartments

What approaches should researchers use to study YLR111W expression levels in different yeast growth conditions?

For comprehensive YLR111W expression analysis:

• Quantitative Western blotting:

  • Collect yeast samples at defined time points under different conditions

  • Extract proteins using standardized protocols with protease inhibitors

  • Separate equivalent protein amounts by SDS-PAGE

  • Blot with YLR111W antibody and quantify band intensities

  • Normalize against housekeeping proteins (e.g., GAPDH, actin, tubulin)

• Flow cytometry applications:

  • Fix and permeabilize yeast cells from different conditions

  • Stain with YLR111W antibody and fluorescent secondary antibody

  • Analyze fluorescence intensity distributions across populations

  • Apply multi-parameter analysis to correlate with cell cycle markers

• Multiplexed immunoassays:

  • Develop bead-based multiplexed assays including YLR111W

  • Simultaneously measure multiple proteins in the same pathway

  • Generate expression profiles across condition time courses

  • Apply statistical methods to identify coordinated expression patterns

• Correlation with transcriptomic data:

  • Compare protein levels detected by YLR111W antibody with mRNA expression

  • Calculate protein-mRNA correlation coefficients across conditions

  • Identify post-transcriptional regulation mechanisms

  • Build integrated regulatory models

• Single-cell analysis:

  • Apply immunofluorescence with YLR111W antibody in fixed yeast

  • Quantify cell-to-cell expression variability within populations

  • Correlate with physiological states and stress responses

  • Identify subpopulations with distinct expression patterns